1. Home
  2. BGLC vs FTFT Comparison

BGLC vs FTFT Comparison

Compare BGLC & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • FTFT
  • Stock Information
  • Founded
  • BGLC N/A
  • FTFT N/A
  • Country
  • BGLC Malaysia
  • FTFT United States
  • Employees
  • BGLC 30
  • FTFT N/A
  • Industry
  • BGLC Medical Specialities
  • FTFT Business Services
  • Sector
  • BGLC Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • BGLC Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • BGLC 9.1M
  • FTFT 8.4M
  • IPO Year
  • BGLC N/A
  • FTFT N/A
  • Fundamental
  • Price
  • BGLC $0.49
  • FTFT $0.47
  • Analyst Decision
  • BGLC
  • FTFT
  • Analyst Count
  • BGLC 0
  • FTFT 0
  • Target Price
  • BGLC N/A
  • FTFT N/A
  • AVG Volume (30 Days)
  • BGLC N/A
  • FTFT 149.0K
  • Earning Date
  • BGLC N/A
  • FTFT 08-19-2024
  • Dividend Yield
  • BGLC N/A
  • FTFT N/A
  • EPS Growth
  • BGLC N/A
  • FTFT N/A
  • EPS
  • BGLC N/A
  • FTFT N/A
  • Revenue
  • BGLC N/A
  • FTFT $36,594,555.00
  • Revenue This Year
  • BGLC N/A
  • FTFT N/A
  • Revenue Next Year
  • BGLC N/A
  • FTFT N/A
  • P/E Ratio
  • BGLC N/A
  • FTFT N/A
  • Revenue Growth
  • BGLC N/A
  • FTFT 53.89
  • 52 Week Low
  • BGLC N/A
  • FTFT $0.40
  • 52 Week High
  • BGLC N/A
  • FTFT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 51.59
  • FTFT 39.00
  • Support Level
  • BGLC $0.49
  • FTFT $0.40
  • Resistance Level
  • BGLC $0.59
  • FTFT $0.49
  • Average True Range (ATR)
  • BGLC 0.03
  • FTFT 0.05
  • MACD
  • BGLC 0.00
  • FTFT 0.01
  • Stochastic Oscillator
  • BGLC 37.04
  • FTFT 48.57

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.

Share on Social Networks: